Template | Type 2 diabetes | Glaucoma |
---|---|---|
Arm | 7.01 (\(\pm 2.79\)) | 4.8 (\(\pm 2.07\)) |
ClinicalTrial | 14.63 (\(\pm 3.07\)) | 15.1 (\(\pm 3.12\)) |
DiffBetweenGroups | 3.61 (\(\pm 0.81\)) | 3.32 (\(\pm 0.72\)) |
Endpoint | 1.68 (\(\pm 0.85\)) | 1.81 (\(\pm 0.95\)) |
EvidenceQuality | 1.00 (\(\pm 0.00\)) | 4.00 (\(\pm 0.00\)) |
Intervention | 1.91 (\(\pm 0.79\)) | 2.24 (\(\pm 0.74\)) |
Medication | 1.98 (\(\pm 1.11\)) | 2.13 (\(\pm 1.17\)) |
Outcome | 2.53 (\(\pm 1.14\)) | 3.45 (\(\pm 1.62\)) |
Population | 3.13 (\(\pm 1.86\)) | 2.32 (\(\pm 1.09\)) |
Publication | 12.45 (\(\pm 3.44\)) | 10.14 (\(\pm 3.79\)) |